Global Plasma-derived Therapies Market Growth (Status and Outlook) 2020-2025
COVID-19, the disease it causes, surfaced in late 2019, and now had become a full-blown crisis worldwide. Over fifty key countries had declared a national emergency to combat coronavirus. With cases spreading, and the epicentre of the outbreak shifting to Europe, North America, India and Latin America, life in these regions has been upended the way it had been in Asia earlier in the developing crisis. As the coronavirus pandemic has worsened, the entertainment industry has been upended along with most every other facet of life. As experts work toward a better understanding, the world shudders in fear of the unknown, a worry that has rocked global financial markets, leading to daily volatility in the U.S. stock markets.
According to this latest study, the 2020 growth of Plasma-derived Therapies will have significant change from previous year. By the most conservative estimates of global Plasma-derived Therapies market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ xx million in 2019. We give this scenario a XX% probability, where under the scenario the supply chain will start to recover and quarantines and travel bans will ease, over the Q2. Longer-term, the effect of COVID-19 will be felt throughout the year with some degree of harm done by the virus. Over the next five years the Plasma-derived Therapies market will register a XX% CAGR in terms of revenue, the global market size will reach US$ XX million by 2025.
This report presents a comprehensive overview, market shares, and growth opportunities of Plasma-derived Therapies market by product type, application, key manufacturers and key regions and countries.
This study specially analyses the impact of Covid-19 outbreak on the Plasma-derived Therapies, covering the supply chain analysis, impact assessment to the Plasma-derived Therapies market size growth rate in several scenarios, and the measures to be undertaken by Plasma-derived Therapies companies in response to the COVID-19 epidemic.
Segmentation by product type:
Albumin
Immunoglobulin
Factor VIII
Others
Segmentation by Application:
Hemophilia
Primary Immunodeficiencies (PIDs)
Idiopathic Thrombocytopenic Purpura (ITP)
COVID-19
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/players in the market. The key players covered in this report:
CSL Behring LLC
Grifols
Shire
Kedrion
Takeda
Bayer
Bio Products Laboratory (BPL)
Biotest
LFB
Octaparma
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key players and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Plasma-derived Therapies market size by key regions/countries, type and application.
To understand the structure of Plasma-derived Therapies market by identifying its various subsegments.
Focuses on the key global Plasma-derived Therapies players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Plasma-derived Therapies with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the size of Plasma-derived Therapies submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 What is the Impact of Covid-19 Outbreak On the Plasma-derived Therapies?
1.8.1 Optimistic Scenario: COVID-19 Is Contained by May or June, with Normalcy Returning to Global Operations Through the End of Q2.
1.8.2 Conservative Scenario: COVID-19 Remains Prevalent, with Continued Impacts Lasting Into Q4.
1.8.3 Estimated Impact of the Coronavirus (COVID-19) Epidemic on the Global Plasma-derived Therapies Market Size in 2020, by Scenario
1.8.4 Corporate Strategy the Manufacturers Should Be Thinking About Right Now
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Plasma-derived Therapies Market Size 2021-2025
2.1.2 Plasma-derived Therapies Market Size CAGR by Region
2.2 Plasma-derived Therapies Segment by Type
2.2.1 Albumin
2.2.2 Immunoglobulin
2.2.3 Factor VIII
2.2.4 Others
2.3 Plasma-derived Therapies Market Size by Type
2.3.1 Global Plasma-derived Therapies Market Size Market Share by Type (2021-2025)
2.3.2 Global Plasma-derived Therapies Market Size Growth Rate by Type (2021-2025)
2.4 Plasma-derived Therapies Segment by Application
2.4.1 Hemophilia
2.4.2 Primary Immunodeficiencies (PIDs)
2.4.3 Idiopathic Thrombocytopenic Purpura (ITP)
2.4.4 COVID-19
2.4.5 Others
2.5 Plasma-derived Therapies Market Size by Application
2.5.1 Global Plasma-derived Therapies Market Size Market Share by Application (2021-2025)
2.5.2 Global Plasma-derived Therapies Market Size Growth Rate by Application (2021-2025)
3 Plasma-derived Therapies Key Players
3.1 Date of Key Players Enter into Plasma-derived Therapies
3.2 Key Players Plasma-derived Therapies Product Offered
3.3 Key Players Plasma-derived Therapies Funding/Investment Analysis
3.4 Funding/Investment
3.4.1 Funding/Investment by Regions
3.4.2 Funding/Investment by End-Industry
3.5 Key Players Plasma-derived Therapies Valuation & Market Capitalization
3.6 Key Players Mergers & Acquisitions, Expansion Plans
3.7 Market Ranking
3.8 New Product/Technology Launches
3.9 Partnerships, Agreements, and Collaborations
3.10 Mergers and Acquisitions
4 Plasma-derived Therapies by Regions
4.1 Plasma-derived Therapies Market Size by Regions (2015-2020)
4.2 Americas Plasma-derived Therapies Market Size Growth (2015-2020)
4.3 APAC Plasma-derived Therapies Market Size Growth (2015-2020)
4.4 Europe Plasma-derived Therapies Market Size Growth (2015-2020)
5 Americas
5.1 Americas Plasma-derived Therapies Market Size by Countries (2021-2025)
5.2 Americas Plasma-derived Therapies Market Size by Type (2021-2025)
5.3 Americas Plasma-derived Therapies Market Size by Application (2021-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
5.8 Key Economic Indicators of Few Americas Countries
6 APAC
6.1 APAC Plasma-derived Therapies Market Size by Regions
6.2 APAC Plasma-derived Therapies Market Size by Type (2021-2025)
6.3 APAC Plasma-derived Therapies Market Size by Application (2021-2025)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Regions
7 Europe
7.1 Europe Plasma-derived Therapies by Countries (2021-2025)
7.2 Europe Plasma-derived Therapies Market Size by Type (2021-2025)
7.3 Europe Plasma-derived Therapies Market Size by Application (2021-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Key Economic Indicators of Few Europe Countries
8 Market Drivers, Challenges and Trends
8.1 Market Drivers and Impact
8.1.1 Growing Demand from Key Regions
8.1.2 Growing Demand from Key Applications and Potential Industries
8.2 Market Challenges and Impact
8.3 Market Trends
8.4 Market Ecosystem and Roles
9 Key Investors in Plasma-derived Therapies
9.1 Company A
9.1.1 Company A Company Details
9.1.2 Company Description
9.1.3 Companies Invested by Company A
9.1.4 Company A Key Development and Market Layout
9.2 Company B
9.2.1 Company B Company Details
9.2.2 Company Description
9.2.3 Companies Invested by Company B
9.2.4 Company B Key Development and Market Layout
9.3 Company C
9.3.1 Company C Company Details
9.3.2 Company Description
9.3.3 Companies Invested by Company C
9.3.4 Company C Key Development and Market Layout
9.4 Company D
9.5 ……
10 Key Players Analysis
10.1 CSL Behring LLC
10.1.1 CSL Behring LLC Company Information
10.1.2 Plasma-derived Therapies Product Offered
10.1.3 CSL Behring LLC Plasma-derived Therapies Market Size (2020 VS 2025)
10.1.4 Main Business Overview
10.1.5 CSL Behring LLC Latest Developments
10.2 Grifols
10.2.1 Grifols Company Information
10.2.2 Plasma-derived Therapies Product Offered
10.2.3 Grifols Plasma-derived Therapies Market Size (2020 VS 2025)
10.2.4 Main Business Overview
10.2.5 Grifols Latest Developments
10.3 Shire
10.3.1 Shire Company Information
10.3.2 Plasma-derived Therapies Product Offered
10.3.3 Shire Plasma-derived Therapies Market Size (2020 VS 2025)
10.3.4 Main Business Overview
10.3.5 Shire Latest Developments
10.4 Kedrion
10.4.1 Kedrion Company Information
10.4.2 Plasma-derived Therapies Product Offered
10.4.3 Kedrion Plasma-derived Therapies Market Size (2020 VS 2025)
10.4.4 Main Business Overview
10.4.5 Kedrion Latest Developments
10.5 Takeda
10.5.1 Takeda Company Information
10.5.2 Plasma-derived Therapies Product Offered
10.5.3 Takeda Plasma-derived Therapies Market Size (2020 VS 2025)
10.5.4 Main Business Overview
10.5.5 Takeda Latest Developments
10.6 Bayer
10.6.1 Bayer Company Information
10.6.2 Plasma-derived Therapies Product Offered
10.6.3 Bayer Plasma-derived Therapies Market Size (2020 VS 2025)
10.6.4 Main Business Overview
10.6.5 Bayer Latest Developments
10.7 Bio Products Laboratory (BPL)
10.7.1 Bio Products Laboratory (BPL) Company Information
10.7.2 Plasma-derived Therapies Product Offered
10.7.3 Bio Products Laboratory (BPL) Plasma-derived Therapies Market Size (2020 VS 2025)
10.7.4 Main Business Overview
10.7.5 Bio Products Laboratory (BPL) Latest Developments
10.8 Biotest
10.8.1 Biotest Company Information
10.8.2 Plasma-derived Therapies Product Offered
10.8.3 Biotest Plasma-derived Therapies Market Size (2020 VS 2025)
10.8.4 Main Business Overview
10.8.5 Biotest Latest Developments
10.9 LFB
10.9.1 LFB Company Information
10.9.2 Plasma-derived Therapies Product Offered
10.9.3 LFB Plasma-derived Therapies Market Size (2020 VS 2025)
10.9.4 Main Business Overview
10.9.5 LFB Latest Developments
10.10 Octaparma
10.10.1 Octaparma Company Information
10.10.2 Plasma-derived Therapies Product Offered
10.10.3 Octaparma Plasma-derived Therapies Market Size (2020 VS 2025)
10.10.4 Main Business Overview
10.10.5 Octaparma Latest Developments
11 Research Findings and Conclusion
Tables and Figures
List of Tables
Table 1. Estimated Impact of the Coronavirus (COVID-19) Epidemic on the Global Plasma-derived Therapies Market Size in 2020, by Scenario
Table 2. COVID-19: Measures to be Undertaken by Plasma-derived Therapies Companies
Table 3. Research Methodology
Table 4. Data Source
Table 5. Plasma-derived Therapies Market Size CAGR by Region (2021-2025) ($ Millions)
Table 6. Major Players of Albumin
Table 7. Major Players of Immunoglobulin
Table 8. Major Players of Factor VIII
Table 9. Major Players of Others
Table 10. Global Market Size by Type (2021-2025) ($ Millions)
Table 11. Global Plasma-derived Therapies Market Size Market Share by Type (2021-2025)
Table 12. Global Plasma-derived Therapies Market Size by Application (2021-2025) ($ Millions)
Table 13. Global Plasma-derived Therapies Market Size Market Share by Application (2021-2025)
Table 14. Date of Global Key Players Enter into Plasma-derived Therapies Market
Table 15. Global Key Players Plasma-derived Therapies Product Offered
Table 16. Key Players Plasma-derived Therapies Funding/Investment ($ Millions)
Table 17. Funding/Investment by Regions
Table 18. Funding/Investment by End Industry
Table 19. Key Players Plasma-derived Therapies Valuation & Market Capitalization ($ Millions)
Table 20. Key Players Mergers & Acquisitions, Expansion Plans
Table 21. Plasma-derived Therapies New Product/Technology Launches
Table 22. Plasma-derived Therapies Industry Partnerships, Agreements, and Collaborations
Table 23. Plasma-derived Therapies Industry Mergers and Acquisitions
Table 24. Global Plasma-derived Therapies Market Size by Regions 2021-2025 ($ Millions)
Table 25. Global Plasma-derived Therapies Market Size Market Share by Regions 2021-2025
Table 26. Americas Plasma-derived Therapies Market Size by Countries (2021-2025) ($ Millions)
Table 27. Americas Plasma-derived Therapies Market Size Market Share by Countries (2021-2025)
Table 28. Americas Plasma-derived Therapies Market Size by Type (2021-2025) ($ Millions)
Table 29. Americas Plasma-derived Therapies Market Size Market Share by Type (2021-2025)
Table 30. Americas Plasma-derived Therapies Market Size by Application (2021-2025) ($ Millions)
Table 31. Americas Plasma-derived Therapies Market Size Market Share by Application (2021-2025)
Table 32. APAC Plasma-derived Therapies Market Size by Regions (2021-2025) ($ Millions)
Table 33. APAC Plasma-derived Therapies Market Size Market Share by Regions (2021-2025)
Table 34. APAC Plasma-derived Therapies Market Size by Type (2021-2025) ($ Millions)
Table 35. APAC Plasma-derived Therapies Market Size Market Share by Type (2021-2025)
Table 36. APAC Plasma-derived Therapies Market Size by Application (2021-2025) ($ Millions)
Table 37. APAC Plasma-derived Therapies Market Size Market Share by Application (2021-2025)
Table 38. Europe Plasma-derived Therapies Market Size by Countries (2021-2025) ($ Millions)
Table 39. Europe Plasma-derived Therapies Market Size Market Share by Countries (2021-2025)
Table 40. Europe Plasma-derived Therapies Market Size by Type (2021-2025) ($ Millions)
Table 41. Europe Plasma-derived Therapies Market Size Market Share by Type (2021-2025)
Table 42. Europe Plasma-derived Therapies Market Size by Application (2021-2025) ($ Millions)
Table 43. Europe Plasma-derived Therapies Market Size Market Share by Application (2021-2025)
Table 44. Key and Potential Regions of Plasma-derived Therapies
Table 45. Key Application and Potential Industries of Plasma-derived Therapies
Table 46. Key Challenges of Plasma-derived Therapies
Table 47. Key Trends of Plasma-derived Therapies
Table 48. Company A Company Details
Table 49. Companies Invested by Company A
Table 50. Company A Key Development and Market Layout
Table 51. Company B Company Details
Table 52. Companies Invested by Company B
Table 53. Company B Key Development and Market Layout
Table 54. Company C Company Details
Table 55. Companies Invested by Company C
Table 56. Company C Key Development and Market Layout
Table 57. Company C Company Details
Table 58. Companies Invested by Company C
Table 59. Company C Key Development and Market Layout
Table 60. CSL Behring LLC Basic Information, Head Office, Major Market Areas and Its Competitors
Table 61. CSL Behring LLC Plasma-derived Therapies Market Size (2020 VS 2025)
Table 62. Grifols Basic Information, Head Office, Major Market Areas and Its Competitors
Table 63. Grifols Plasma-derived Therapies Market Size (2020 VS 2025)
Table 64. Shire Basic Information, Head Office, Major Market Areas and Its Competitors
Table 65. Shire Plasma-derived Therapies Market Size (2020 VS 2025)
Table 66. Kedrion Basic Information, Head Office, Major Market Areas and Its Competitors
Table 67. Kedrion Plasma-derived Therapies Market Size (2020 VS 2025)
Table 68. Takeda Basic Information, Head Office, Major Market Areas and Its Competitors
Table 69. Takeda Plasma-derived Therapies Market Size (2020 VS 2025)
Table 70. Bayer Basic Information, Head Office, Major Market Areas and Its Competitors
Table 71. Bayer Plasma-derived Therapies Market Size (2020 VS 2025)
Table 72. Bio Products Laboratory (BPL) Basic Information, Head Office, Major Market Areas and Its Competitors
Table 73. Bio Products Laboratory (BPL) Plasma-derived Therapies Market Size (2020 VS 2025)
Table 74. Biotest Basic Information, Head Office, Major Market Areas and Its Competitors
Table 75. Biotest Plasma-derived Therapies Market Size (2020 VS 2025)
Table 76. LFB Basic Information, Head Office, Major Market Areas and Its Competitors
Table 77. LFB Plasma-derived Therapies Market Size (2020 VS 2025)
Table 78. Octaparma Basic Information, Head Office, Major Market Areas and Its Competitors
Table 79. Octaparma Plasma-derived Therapies Market Size (2020 VS 2025)
List of Figures
Figure 1. Picture of Plasma-derived Therapies
Figure 2. Plasma-derived Therapies Report Years Considered
Figure 3. Market Research Methodology
Figure 4. Global Plasma-derived Therapies Market Size Growth Rate 2021-2025 ($ Millions)
Figure 5. Plasma-derived Therapies Market Size by Region (2020 & 2025) ($ millions)
Figure 6. Global Plasma-derived Therapies Market Size Market Share by Type (2021-2025)
Figure 7. Global Albumin Market Size Growth Rate
Figure 8. Global Immunoglobulin Market Size Growth Rate
Figure 9. Global Factor VIII Market Size Growth Rate
Figure 10. Global Others Market Size Growth Rate
Figure 11. Plasma-derived Therapies Consumed in Hemophilia
Figure 12. Global Plasma-derived Therapies Market: Hemophilia (2021-2025) ($ Millions)
Figure 13. Global Hemophilia YoY Growth ($ Millions)
Figure 14. Plasma-derived Therapies Consumed in Primary Immunodeficiencies (PIDs)
Figure 15. Global Plasma-derived Therapies Market: Primary Immunodeficiencies (PIDs) (2021-2025) ($ Millions)
Figure 16. Global Primary Immunodeficiencies (PIDs) YoY Growth ($ Millions)
Figure 17. Plasma-derived Therapies Consumed in Idiopathic Thrombocytopenic Purpura (ITP)
Figure 18. Global Plasma-derived Therapies Market: Idiopathic Thrombocytopenic Purpura (ITP) (2021-2025) ($ Millions)
Figure 19. Global Idiopathic Thrombocytopenic Purpura (ITP) YoY Growth ($ Millions)
Figure 20. Plasma-derived Therapies Consumed in COVID-19
Figure 21. Global Plasma-derived Therapies Market: COVID-19 (2021-2025) ($ Millions)
Figure 22. Global COVID-19 YoY Growth ($ Millions)
Figure 23. Plasma-derived Therapies Consumed in Others
Figure 24. Global Plasma-derived Therapies Market: Others (2021-2025) ($ Millions)
Figure 25. Global Others YoY Growth ($ Millions)
Figure 26. Global Plasma-derived Therapies Market Size Market Share by Application (2021-2025)
Figure 27. Global Plasma-derived Therapies Market Size in Hemophilia Growth Rate
Figure 28. Global Plasma-derived Therapies Market Size in Primary Immunodeficiencies (PIDs) Growth Rate
Figure 29. Global Plasma-derived Therapies Market Size in Idiopathic Thrombocytopenic Purpura (ITP) Growth Rate
Figure 30. Global Plasma-derived Therapies Market Size in COVID-19 Growth Rate
Figure 31. Global Plasma-derived Therapies Market Size in Others Growth Rate
Figure 32. Funding/Investment
Figure 33. Global Plasma-derived Therapies Market Size Market Share by Regions 2021-2025
Figure 34. Americas Plasma-derived Therapies Market Size 2021-2025 ($ Millions)
Figure 35. APAC Plasma-derived Therapies Market Size 2021-2025 ($ Millions)
Figure 36. Europe Plasma-derived Therapies Market Size 2021-2025 ($ Millions)
Figure 37. Americas Plasma-derived Therapies Market Size Market Share by Countries in 2020
Figure 38. Americas Plasma-derived Therapies Market Size Market Share by Type in 2020
Figure 39. Americas Plasma-derived Therapies Market Size Market Share by Application in 2020
Figure 40. United States Plasma-derived Therapies Market Size Growth 2021-2025 ($ Millions)
Figure 41. Canada Plasma-derived Therapies Market Size Growth 2021-2025 ($ Millions)
Figure 42. Mexico Plasma-derived Therapies Market Size Growth 2021-2025 ($ Millions)
Figure 43. APAC Plasma-derived Therapies Market Size Market Share by Regions in 2020
Figure 44. APAC Plasma-derived Therapies Market Size Market Share by Type in 2020
Figure 45. APAC Plasma-derived Therapies Market Size Market Share by Application in 2020
Figure 46. China Plasma-derived Therapies Market Size Growth 2021-2025 ($ Millions)
Figure 47. Japan Plasma-derived Therapies Market Size Growth 2021-2025 ($ Millions)
Figure 48. Korea Plasma-derived Therapies Market Size Growth 2021-2025 ($ Millions)
Figure 49. Southeast Asia Plasma-derived Therapies Market Size Growth 2021-2025 ($ Millions)
Figure 50. India Plasma-derived Therapies Market Size Growth 2021-2025 ($ Millions)
Figure 51. Australia Plasma-derived Therapies Market Size Growth 2021-2025 ($ Millions)
Figure 52. Europe Plasma-derived Therapies Market Size Market Share by Countries in 2020
Figure 53. Europe Plasma-derived Therapies Market Size Market Share by Type in 2020
Figure 54. Europe Plasma-derived Therapies Market Size Market Share by Application in 2020
Figure 55. Germany Plasma-derived Therapies Market Size Growth 2021-2025 ($ Millions)
Figure 56. France Plasma-derived Therapies Market Size Growth 2021-2025 ($ Millions)
Figure 57. UK Plasma-derived Therapies Market Size Growth 2021-2025 ($ Millions)
Figure 58. Italy Plasma-derived Therapies Market Size Growth 2021-2025 ($ Millions)
Figure 59. Russia Plasma-derived Therapies Market Size Growth 2021-2025 ($ Millions)
Reason to Buy
- Current and future of Service & Software Market outlook in the developed and emerging markets
- Highlights key business priorities in order to assist companies to realign their business strategies
- The segment that is expected to dominate the Service & Software Market
- Regions that are expected to witness the fastest growth during the forecast period
- Identify the latest developments, Service & Software Market shares, and strategies employed by the major market players
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global Service & Software Market
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets